Webb6 apr. 2024 · MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for … WebbMorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 13.04.2024 / 16:01 CET/CEST Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG. The issuer
MorphoSys 663200 Börse Stuttgart (XSTU)
Webbför 2 dagar sedan · MorphoSys steigen um 2,8 Prozent auf 17,89 Euro und Biotest gewinnen 0,7 Prozent auf 31,00 Euro. Evotec gewinnen 0,2 Prozent auf 18,82 Euro. An der Wall Street verliert der NASDAQ Biotechnology Index 0,1 Prozent auf 4.171 Punkte. Hier verlieren Sarepta Therapeutics 0,9 Prozent auf 137,87 US-Dollar, ... Webb12 apr. 2024 · 7 brokerages have issued 1 year price targets for MorphoSys' stock. Their MOR share price forecasts range from $2.90 to $28.00. On average, they expect the … canadian seeds
300% chance with MorphoSys share? News from BioNTech and …
WebbMorphoSys AG (Morphosys) is commercial-stage biopharmaceutical company that develop monoclonal antibodies for therapeutic and research applications, with focused … Webb13 apr. 2024 · EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 13.04.2024 / 16:02 CET/CEST Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG. The … Webb24 mars 2024 · MorphoSys has 5 employees across 2 locations and €278.27 m in annual revenue in FY 2024. See insights on MorphoSys including office locations, competitors, … fisher lpl